Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands

被引：1

作者：

Zhong, Hui ^{[1
]}

Jiang, Qi ^{[1
]}

Wu, Cong ^{[1
]}

Yu, Huanghe ^{[1
,2
]}

Li, Bin ^{[1
,2
]}

Zhou, Xudong ^{[1
,2
]}

Fu, Ronggeng ^{[1
]}

Wang, Wei ^{[1
,2
]}

Sheng, Wenbing ^{[1
,2
]}

机构：

[1] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China

[2] Hunan Univ Chinese Med, TCM & Ethnomed Innovat & Dev Int Lab, Changsha 410208, Peoples R China

来源：

MOLECULES | 2024年 / 29卷 / 02期

关键词：

artemisinin; bivalent ligands; multi-target molecular docking; antitumor target protein; antitumor activity; BRIDGED PORPHYRINS; IN-VITRO; CANCER; ANTIMALARIAL; DERIVATIVES; POTENT; DIMERS; BCL-2; MECHANISMS; EXPRESSION;

D O I：

10.3390/molecules29020409

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Five artemisinin bivalent ligands molecules 4a-4e were designed, synthesized, and confirmed by 1H NMR, 13C NMR, and low-resolution mass spectrometry, and the bioactivities of the target compounds were investigated against four human tumor cell lines in vitro, including BGC-823, HepG-2, MCF-7, and HCT-116. The results showed 4a, 4d, and 4e exhibited significantly tumor cell inhibitory activity compared with the artemisinin and dihydroartemisinin; compound 4e has good biological activity inhibiting BGC-823 with an IC50 value of 8.30 mu mol/L. Then, the good correlations with biological results were validated by molecular docking through the established bivalent ligands multi-target model, which showed that 4e could bind well with the antitumor protein MMP-9.

引用

页数：14

共 50 条

[1] Phenytoin-based bivalent ligands: Design, synthesis and anticonvulsant activity
Botros, Samir
Khalil, Nadia A.
Naguib, Bassem H.
El-Dash, Yara
ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (12) : 2105 - 2116
[2] Phenytoin-based bivalent ligands: Design, synthesis and anticonvulsant activity
Samir Botros
Nadia A. Khalil
Bassem H. Naguib
Yara El-Dash
Archives of Pharmacal Research, 2012, 35 : 2105 - 2116
[3] Design, Synthesis and Antitumor Activity of Novel Artemisinin Derivatives Using Hybrid Approach
Xie, Lijun
Zhai, Xin
Ren, Lixiang
Meng, Haiyan
Liu, Chun
Zhu, Wufu
Zhao, Yanfang
CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59 (08) : 984 - 990
[4] Design, synthesis, and antitumor activity evaluation of steroidal oximes
Gomes, Ana R.
Pires, Ana S.
Abrantes, Ana M.
Goncalves, Ana C.
Costa, Saul C.
Varela, Carla L.
Silva, Elisiario T.
Botelho, Maria F.
Roleira, Fernanda M. F.
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
[5] Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity
Wang, Xiu-Jun
Qiao, Yue
Jiang, Zi-Rui
He, Jing-Liang
Wang, Bing-Yan
Wan, Jia-Rui
Ji, Jing
Liu, Bin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 111
[6] Design, synthesis, and antitumor activity evaluation of pretubulysin analogs
Xu, Xiangrong
Fan, Meixia
Qi, Junhui
Yao, Lei
CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (03) : 341 - 351
[7] Series of macrocyclic ligands: Synthesis and antitumor activity evaluation in vitro.
Kong, DY
Martell, AE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U18 - U18
[8] Synthesis and evaluation of homo-bivalent GnRHR ligands
Bonger, Kimberly M.
van den Berg, Richard J. B. H. N.
Heitman, Laura H.
IJzerman, Ad P.
Oosterom, Julia
Timmers, Cornelis M.
Overkleeft, Herman S.
van der Marel, Gijsbert A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (14) : 4841 - 4856
[9] Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives
Yue, Lingyun
Pan, Yanna
Wang, Jiaoying
Yue, Lin
Luo, Yuxuan
Lv, Fang
Lv, Jiagang
Chen, Jianping
Zhao, Qingjie
Lin, Haixia
CHEMISTRY & BIODIVERSITY, 2023, 20 (07)
[10] Design, Synthesis and in vitro Antitumor Activities of Novel Bivalent β-Carbolines
Guo Liang
Cao Rihui
Fan Wenxi
Gan Ziyun
Ma Qin
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2016, 37 (06): : 1093 - 1099

← 1 2 3 4 5 →